PTC is a medical abbreviation with several distinct meanings depending on the specialty. The most common uses are percutaneous transhepatic cholangiography (a bile duct imaging procedure), papillary thyroid carcinoma (a type of thyroid cancer), pseudotumor cerebri (a neurological condition causing high pressure in the skull), and plasma thromboplastin component (a blood clotting factor). Less commonly, PTC refers to phenylthiocarbamide, a chemical used in genetic taste-testing studies. Here’s what each one means and why it matters.
Percutaneous Transhepatic Cholangiography
Percutaneous transhepatic cholangiography is an imaging procedure used to examine the bile ducts, the small tubes that carry bile from the liver to the small intestine. Doctors use it when other tests haven’t provided enough detail about the biliary system, or when they need to treat a blockage, a bile leak, or a stricture (narrowing) that’s causing jaundice.
During the procedure, a needle is inserted through the skin and into the liver, typically just below the tenth rib on the right side. The needle is guided into a bile duct, either using X-ray fluoroscopy or ultrasound for more precise targeting. Once in position, a contrast dye is injected so the ducts become visible on imaging. This lets the doctor see exactly where a blockage or narrowing exists. When ultrasound guidance is available, duct targeting tends to be faster and more accurate.
PTC isn’t just diagnostic. During the same session, doctors can place a drain or stent to relieve an obstruction, remove bile duct stones, take tissue samples for biopsy, or even retrieve a foreign body. The overall complication rate for percutaneous biliary procedures ranges from about 11% to 23%, with most complications being relatively minor, such as pain, bile leak, or temporary catheter problems. Bleeding occurs in roughly 1% to 10% of cases.
Papillary Thyroid Carcinoma
Papillary thyroid carcinoma is the most common type of thyroid cancer. It grows in the butterfly-shaped gland at the front of your neck and tends to develop slowly. PTC is often discovered during imaging for an unrelated issue or when a lump is felt during a routine physical exam.
Ultrasound is the preferred tool for evaluating a suspicious thyroid nodule and checking whether cancer has spread to nearby lymph nodes, with a specificity as high as 98% for detecting lymph node involvement. About 45% of papillary thyroid carcinomas carry a specific mutation in the BRAF gene that drives abnormal cell growth. Testing for this mutation can help doctors gauge how aggressive the cancer is likely to be. Features like invasion into blood or lymph vessels, cancer in multiple spots within the thyroid, and rapid cell growth all point toward a worse prognosis.
Treatment and Survival
The standard approach is surgical removal of the thyroid (thyroidectomy), sometimes followed by radioactive iodine therapy to destroy any remaining thyroid tissue or cancer cells. Radioactive iodine works because well-differentiated thyroid cancer cells, including most papillary cases, still absorb iodine the way normal thyroid cells do. This therapy is typically recommended when the tumor is larger than 2 cm with at least one additional risk factor (such as spread beyond the thyroid, age 45 or older, or lymph node involvement), or when cancer has spread to distant sites regardless of tumor size. If thyroglobulin levels remain elevated 6 to 12 weeks after surgery, that’s another signal that residual cancer cells may be present.
The outlook for papillary thyroid carcinoma is among the best of any cancer. For thyroid cancer that hasn’t spread beyond the gland, the five-year survival rate is 99.9%. Even when cancer has reached regional lymph nodes, five-year survival is 98.1%. Only when thyroid cancer has spread to distant organs does the rate drop significantly, to about 50%, and distant spread at diagnosis occurs in only about 3% of cases.
Pseudotumor Cerebri
Pseudotumor cerebri, also called idiopathic intracranial hypertension, is a condition where pressure inside the skull rises for no obvious structural reason. There’s no tumor, no blocked fluid pathway, and brain imaging looks normal. The name literally means “false brain tumor” because the symptoms mimic those of a brain mass.
The elevated pressure comes from too much cerebrospinal fluid (CSF) building up, either because the body isn’t reabsorbing it efficiently or because it’s being produced in excess. This creates a constellation of symptoms: persistent headaches, brief episodes of blindness lasting a few seconds in one or both eyes, and a distinctive whooshing sound in the head that pulses with your heartbeat (pulsatile tinnitus). The headaches can be severe and daily, often worsening with changes in position.
Diagnosis follows the Modified Dandy Criteria, which require signs of increased pressure in the skull, a normal neurological exam (aside from specific findings like swelling of the optic nerve), normal brain imaging, and a CSF opening pressure above 25 cm of water in adults or 28 cm in children. The most serious complication is permanent vision loss from sustained pressure on the optic nerve, which makes early diagnosis and treatment critical.
Plasma Thromboplastin Component
Plasma thromboplastin component is an older name for Factor IX, a protein essential to blood clotting. Factor IX works within the body’s internal clotting cascade. When you’re injured, activated Factor IX pairs with another protein (Factor VIIIa) on cell surfaces in the presence of calcium to form a complex that activates the next step in the clotting chain, ultimately leading to the production of thrombin and the formation of a stable blood clot.
Normal Factor IX levels range from 50% to 200% of a laboratory’s reference value. A deficiency in Factor IX causes hemophilia B, a bleeding disorder where the blood doesn’t clot properly. People with hemophilia B experience prolonged bleeding after injuries or surgery and may bleed spontaneously into joints and muscles. The term “plasma thromboplastin component” is rarely used in modern clinical practice, but it still appears in older textbooks and occasionally on lab reports.
PTC in Genetics: The Taste Test
Outside the clinical setting, PTC also stands for phenylthiocarbamide, a synthetic chemical used in one of the most well-known genetics demonstrations. Some people taste PTC as intensely bitter, while roughly one-third of the population can’t taste it at all. This difference is almost entirely determined by three small variations in a single gene called TAS2R38. People who inherit the “PAV” version of this gene from both parents are strong tasters, while those with two copies of the “AVI” version are non-tasters. If you ever placed a small paper strip on your tongue in a biology class to test whether you could taste bitterness, that was a PTC taste test.